SCIENTIFIC RESOURCES
On-Demand Webinars

See how industry pioneers are revealing the true immune biology at each development stage.

All
  • All
  • Optofluidic
  • Proteomics
  • Technology
Optofluidic
Speaker: Dr. Michael Wilson, Professor of Neurology, University of California, San Francisco
Autoantibody Discovery in Neuroinflammatory Disease
Optofluidic
Speaker: Vincent Pai, Director of Product Management, Bruker Cellular Analysis
Autoantibody Discovery on the Beacon® Platform
Optofluidic
Speaker: Joseph Zenga, MD, Associate Professor, Division Chief, Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin
Advancing Single-Cell Methods in Solid Tumor Oncology with Bruker’s Optofluidic Platform
Optofluidic
Speaker: Edward Han, PhD, Product Manager, Bruker Cellular Analysis
Revolutionizing Functional Immune Cell Screening and Therapy Development with the Beacon Platform
Optofluidic
Speaker: Robert Carnahan, PhD, Associate Director, Vanderbilt Vaccine Center | Lauren Williamson, PhD, Research Assistant Professor, Vanderbilt University
Therapeutic Antibody Discovery: Selecting Effective Candidates for Emerging Viral Threats
Optofluidic
Speaker: Dr. Kate Malecek, Director of Beacon Center for Single Cell Biology at Caltech
Multiplexed and Quantitative Assays for Enhancing Antibody Discovery
Optofluidic
Speaker:
Vikram Devgan, PhD, Vice President of Global Marketing, BCA | Stefan Eichmüller, PhD, Apl. Professor, Head of the Research Group GMP & T Cell Therapy, Qualified Person German Cancer Research Center (DKFZ) | Anthony E. Zamora, PhD, Assistant Professor, Medical College of Wisconsin, Department of Medicine, Division of Hematology & Oncology, and Department of Microbiology & Immunology | François Romagné, Scientific Director MImAbs | Xiaoxiao Wang, PhD., Vice President of Antibody Discovery and ADC Platform, Nona Bioscience | Shu Wang, Ph.D., Principal Investigator at Incyte
Roundtable: Understand the Life of Single Cells
Optofluidic
Speaker: Shu Wang, Ph.D., Principal Investigator at Incyte
Development of an On-Chip Binding Assay to Select Clones Producing High Quality Bispecific Antibodies
Optofluidic
Speaker: François Romagné, Scientific Director MImAbs
Antibody and Cell Therapy Development: The Life of Single Cells on Beacon® Platform
Optofluidic
Speaker: Anthony E. Zamora, PhD, Assistant Professor, Medical College of Wisconsin, Department of Medicine, Division of Hematology & Oncology, and Department of Microbiology & Immunology
Leveraging Real-Time Biology to Streamline the Discovery, Validation, and Translation of Cell-Based Therapies for Cancer
Optofluidic
Speaker: Stefan Eichmüller, PhD, Apl. Professor, Head of the Research Group GMP & T Cell Therapy, Qualified Person German Cancer Research Center (DKFZ), D210, Im Neuenheimer Feld 280, Heidelberg
Identification of Tumor-Reactive T Cell Receptors Through Functional Single Cell Interaction Analyses for Personalized T Cell Therapy
Optofluidic
Speaker: Vikram Devgan, PhD, Vice President of Global Marketing, Bruker Cellular Analysis
Harnessing the Power of the Beacon Platform to Accelerate Antibody and Cell Therapy Development
Optofluidic
Speaker: Xiaoxiao Wang, PhD., Vice President of Antibody Discovery and ADC Platform, Nona Bioscience
Full Human Antibody Discovery with Beacon® and Harbour Mice®
Optofluidic
Speaker: Vincent Pai, Associate Director, Product Management, Bruker Cellular Analysis
Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery
Optofluidic
Speaker: Patrick Schmidt, PhD, Senior Research Associate, National Center for Tumor Diseases (NCT), German Center Research Center (DKFZ)
How to Speed Up the Cell Therapy Development Processes: Advancing CAR T Manufacturing Using Single Cell Analysis
Optofluidic
Speaker: François Romagné, PhD, Professor, ImmunoTechnology, Aix Marseille University, Scientific Director, MI-mAbs
Accelerating Antibody Discovery for Difficult Targets
Optofluidic
Speaker: Anthony E. Zamora, PhD, Assistant Professor, Medicine (Hematology and Oncology) & Microbiology & Immunology
Harnessing the Power of Single Cell Technologies to Build More Effective Cell Therapies
Optofluidic
Speaker: Anupam Singhal, PhD, Senior Manager, Technology Development, Berkeley Lights
Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2 and Other Viral Pandemics
Optofluidic
Speaker: Anupam Singhal, PhD, Senior Manager, Technology Development, Berkeley Lights
Antibody Discovery: Select Better Lead Candidates in Under 1 Week
Optofluidic
Speaker: Colby A. Souders, PhD, Chief Scientific Officer, Abveris
Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape
Optofluidic
Speaker: Mark White, PhD, Sr. Director, T Cell Discovery, Berkeley Lights
Maximize Functional Characterization of Your Precious T Cell Samples
Optofluidic
Speaker: Anupam Singhal, PhD, Senior Manager, Technology Development, Berkeley Lights
Accelerating Target-to-Lead Antibody Candidate Selection Using the Beacon System
Optofluidic
Speaker: Rachel Ferguson, Associate Scientist III, Cell Line Development, Biogen
Evaluation of Novel “Beacon” Cell Screening Technology for Improved and Expedited Cell Line Development
Optofluidic
Speaker: Dr. Keith Breinlinger, CTO, Berkeley Lights
Implementing the Beacon Platform for the Next Generation of Cell Line Development